Thema: US90184D1000
TWST, US90184D1000
deal-4131445.jpg - Foto: THN
Twist Bioscience stock advances MRD research with faster panels
Twist Bioscience stock is in focus after the company launched MRD Express for faster molecular residual disease research. Fiscal results follow on November 12.
ad-hoc-news.de, heute 13:54 Uhr
TWST, US90184D1000
TD Cowen raises target for Twist Bioscience stock to USD ...
Twist Bioscience stock costs EUR 131.65 on October 27, 2026. Results are due November 12, 2026 after fiscal third-quarter revenue rose 23.2 percent.
ad-hoc-news.de, 27.10.26 14:21 Uhr
TWST, US90184D1000
Twist Bioscience officer proposes 2,245-share sale of Twist ...
TD Cowen raised its target to USD 190 from USD 115 on October 13, 2026. A 2,245-share sale filed October 23 involves Twist Bioscience stock.
ad-hoc-news.de, 25.10.26 13:18 Uhr
TWST, US90184D1000
TD Cowen lifts target to USD 190 for Twist Bioscience stock ...
TD Cowen raised its target to USD 190 on October 13, 2026. Twist Bioscience stock was EUR 120.18 at Lang & Schwarz on October 20, 2026.
ad-hoc-news.de, 20.10.26 14:24 Uhr
TWST, US90184D1000
TD Cowen raises target to USD 190 for Twist Bioscience stock ...
TD Cowen lifted its target to USD 190 on October 13, 2026. Twist Bioscience stock faces November 13, 2026 after USD 118.38 million third-quarter revenue.
ad-hoc-news.de, 18.10.26 12:42 Uhr
TWST, US90184D1000
TD Cowen raises target for Twist Bioscience stock to USD ...
Twist Bioscience stock was at EUR 128.08 on October 15, 2026. Fiscal third-quarter revenue rose 23.20 percent to USD 118.38 million.
ad-hoc-news.de, 15.10.26 12:58 Uhr
TWST, US90184D1000
Leerink raises target for Twist Bioscience stock from USD ...
